Ozan Pamir's Insider Trades & SAST Disclosures
Ozan Pamir's most recent trade in Niagen Bioscience Inc. was a trade of 17,230 Employee Stock Options (right to buy) done . Disclosure was reported to the exchange on Feb. 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ozan Pamir.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Niagen Bioscience Inc. | Ozan Pamir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 17,230 | 17,230 | - | - | Employee Stock Options (right to buy) | |
| Niagen Bioscience Inc. | Ozan Pamir | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.36 per share. | 22 Nov 2024 | 2,907 | 2,907 (0%) | 0% | 7.4 | 21,397 | Common Stock |
| Niagen Bioscience Inc. | Ozan Pamir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2024 | 146,544 | 146,544 | - | - | Employee Stock Options (right to buy) | |
| 180 Life Sciences Corp | Ozan Pamir | CFO | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 18 May 2023 | 5,162 | 8,983 | - | 1.0 | 5,214 | Common Stock |
| 180 Life Sciences Corp | Ozan Pamir | Interim CFO | Purchase of securities on an exchange or from another person at price $ 3.87 per share. | 10 Dec 2021 | 3,800 | 76,408 | - | 3.9 | 14,706 | Common Stock |
| 180 Life Sciences Corp | Ozan Pamir | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges